1. Home
  2. NBIX vs OVV Comparison

NBIX vs OVV Comparison

Compare NBIX & OVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$172.01

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Ovintiv Inc. (DE)

OVV

Ovintiv Inc. (DE)

HOLD

Current Price

$56.50

Market Cap

15.5B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
OVV
Founded
1992
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.5B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
NBIX
OVV
Price
$172.01
$56.50
Analyst Decision
Strong Buy
Buy
Analyst Count
22
17
Target Price
$180.91
$58.35
AVG Volume (30 Days)
1.1M
3.0M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
1.96%
EPS Growth
41.95
13.54
EPS
1.91
N/A
Revenue
$161,626,000.00
$8,908,000,000.00
Revenue This Year
$24.73
$5.45
Revenue Next Year
$13.14
N/A
P/E Ratio
$89.54
N/A
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$35.47
52 Week High
$181.18
$63.46

Technical Indicators

Market Signals
Indicator
NBIX
OVV
Relative Strength Index (RSI) 56.82 55.05
Support Level $153.96 $51.64
Resistance Level N/A $62.74
Average True Range (ATR) 4.57 1.21
MACD -0.61 0.47
Stochastic Oscillator 49.24 85.29

Price Performance

Historical Comparison
NBIX
OVV

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About OVV Ovintiv Inc. (DE)

Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.

Share on Social Networks: